Pharmaceuticals, Biotechnology and Life Sciences
FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#immunotherapy–ImmunSYS, Inc., a clinical stage biotechnology company focused on the development of YourVaccx™, a new intratumoral immunotherapy…
Company takeover and opening of Hasselt office in Belgium HASSELT, Belgium–(BUSINESS WIRE)–CNT Management Consulting, a leading SAP consultancy in Austria…
BOSTON–(BUSINESS WIRE)–$flks–Flex Pharma, Inc. (Nasdaq: FLKS) today announced that on or about June 27, 2019 it will mail a supplement…
Compound Designed to Enhance Synaptic Integrity and Improve Learning, Memory and Function CAMBRIDGE, Mass.–(BUSINESS WIRE)–Rodin Therapeutics today announced positive Phase…
Dr. Reddy’s is launching Tobramycin Inhalation Solution, USP a therapeutic equivalent generic version of TOBI
It is approved for the treatment of type 2 diabetes and currently in Phase III trials for the treatment of type 1 diabetes, as well as for chronic kidney disease including diabetic nephropathy.
Keytruda’s market potential in this indication remains limited due to its approval for primary mediastinal B-cell lymphoma (PMBCL), which only accounts for a small percentage of non-Hodgkin’s lymphoma (NHL) patients.
Tilray has imported medical cannabis oral solutions in bulk into the United Kingdom from its Good Manufacturing Practices (GMP)-certified facility in Canada.
Imeglimin in combination with insulin Phase 3 TIMES 3 16-week, double-blind, placebo-controlled, randomized part of the trial met its primary endpoint with a favorable safety and tolerability profile
FDA has approved Ipsen’s new pre-filled syringe for Somatuline
Depot.